| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,587 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,594 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,070 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,374 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,032 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
607 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7456146 |
Lytic peptide prodrugs |
Nov. 25, 2008 |
| 7455843 |
Adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside |
Nov. 25, 2008 |
| 7455840 |
Compositions and methods to reduce mutagenesis |
Nov. 25, 2008 |
| 7455833 |
Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids |
Nov. 25, 2008 |
| 7452866 |
Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1 |
Nov. 18, 2008 |
| 7452865 |
Antagonistic analogs of GH RH (2003) |
Nov. 18, 2008 |
| 7452859 |
Human bikunin |
Nov. 18, 2008 |
| 7452858 |
Treatment of gestational diabetes |
Nov. 18, 2008 |
| 7452857 |
Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
Nov. 18, 2008 |
| 7452856 |
Antibacterial peptide |
Nov. 18, 2008 |
| 7452543 |
Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
Nov. 18, 2008 |
| 7452539 |
Stabilizing polypeptides which have been exposed to urea |
Nov. 18, 2008 |
| 7449445 |
Conductive peptide nanofiber and method of manufacture of the same |
Nov. 11, 2008 |
| 7449444 |
Hydroxyethyl starch-containing polypeptide compositions |
Nov. 11, 2008 |
| 7449443 |
Method for stabilization of proteins using non-natural amino acids |
Nov. 11, 2008 |
| 7449191 |
Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
Nov. 11, 2008 |
| 7449184 |
Fixed dosing of HER antibodies |
Nov. 11, 2008 |
| 7449182 |
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent |
Nov. 11, 2008 |
| 7449177 |
Remedy for pemphigoid |
Nov. 11, 2008 |
| 7449176 |
Treatment of inflammatory bowel disease with IFN-.gamma. inhibitors |
Nov. 11, 2008 |
| 7446095 |
Peptides modulating caspase activation |
Nov. 4, 2008 |
| 7446091 |
Methods and preparations for curing clinically ill patients |
Nov. 4, 2008 |
| 7446090 |
FSH formulation |
Nov. 4, 2008 |
| 7446089 |
Methods of inhibiting and treating bacterial biofilms by metal chelators |
Nov. 4, 2008 |
| 7445788 |
Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
Nov. 4, 2008 |
| 7445764 |
Carrier-drug conjugate |
Nov. 4, 2008 |
| 7442686 |
Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions |
Oct. 28, 2008 |
| 7442682 |
Transepithelial delivery of peptides with incretin hormone activities |
Oct. 28, 2008 |
| 7442681 |
Method of inhibiting vascular permeability |
Oct. 28, 2008 |
| 7442680 |
Inotropic and diuretic effects of GLP-1 and GLP-1 agonists |
Oct. 28, 2008 |
| 7439418 |
Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
Oct. 21, 2008 |
| 7439234 |
Method for treating cancer patients undergoing chemotherapy |
Oct. 21, 2008 |
| 7439224 |
Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
Oct. 21, 2008 |
| 7439223 |
Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53 |
Oct. 21, 2008 |
| 7439222 |
Process and systems for peptide synthesis |
Oct. 21, 2008 |
| 7439221 |
Methods and compositions for modulating gamete adhesion |
Oct. 21, 2008 |
| 7438921 |
Buttock deformity treatment |
Oct. 21, 2008 |
| 7438920 |
Crystals of hepatitis C virus helicase or fragments thereof comprising a helicase binding pocket |
Oct. 21, 2008 |
| 7438890 |
Binding peptides for carcinoembryonic antigen (CEA) |
Oct. 21, 2008 |
| 7435718 |
CXCR4 antagonist treatment of hematopoietic cells |
Oct. 14, 2008 |
| 7435717 |
Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes |
Oct. 14, 2008 |
| 7435716 |
Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia |
Oct. 14, 2008 |
| 7435421 |
Derivatives of choline binding proteins for vaccines |
Oct. 14, 2008 |
| 7435420 |
Dipeptidyl peptidase IV inhibitors for the treatment of anxiety |
Oct. 14, 2008 |
| 7435419 |
Methods of diagnosing and treating pre-eclampsia or eclampsia |
Oct. 14, 2008 |
| 7435418 |
Receptor for B. anthracis toxin |
Oct. 14, 2008 |
| 7435408 |
Porous particles comprising excipients for deep lung delivery |
Oct. 14, 2008 |
| 7432301 |
Use of S-nitrosothiol signaling to treat disordered control of breathing |
Oct. 7, 2008 |
| 7432251 |
Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R |
Oct. 7, 2008 |
| 7432241 |
Device for treating diabetes and methods thereof |
Oct. 7, 2008 |
|
|
|
